HuMAB companies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HuMAB companies

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Icebrg	6/3/2006 3:53:21 PM
	of 1022

Cuba Approves New Monoclonal Antibody Havana, May 31 (Prensa Latina) Cuban health authorities approved the use of the first monoclonal antibody obtained from transgenic plants in the country, the Cuban News Agency (ACN) reported on Wednesday. The Center for State Control of Medication Quality (CECMED), attached to the Ministry of Public Health, gave the green light to the use of the Cuban-made monoclonal antibody, as a reagent in the purification of the active pharmaceutical ingredient of the vaccine against hepatitis B (Heberbiovac-HB). The antibody, which is produced by the Genetic Engineering and Biotechnology Center (CIGB) in Havana, contributes to reducing the cost of vaccines. The CECMED certifies that both the monoclonal antibody and the new process to produce it follow nationally- and internationally-accepted quality standards for the pharmaceutical industry.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next